A Lab-Grown Coronary Artery Heads Into Its First Human Bypass Trial

Humacyte has opened a 10-patient first-in-human study of a bioengineered blood vessel designed as an off-the-shelf graft for coronary bypass surgery. The design was presented at the American Heart Association meeting; animal data are promising, but no human results exist yet.